ADVM β€” ADVERUM BIOTECHNOLOGIES INC

Ownership history in VANGUARD GROUP INC  Β·  38 quarters on record

This page tracks every 13F SEC filing in which VANGUARD GROUP INC reported a position in ADVERUM BIOTECHNOLOGIES INC (ADVM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

% of Fund (quarterly)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 872,041 -11,896 -1.3% 0.00% $4.0M β€”
2025 Q2 REDUCED 883,937 -145,389 -14.1% 0.00% $1.9M β€”
2025 Q1 REDUCED 1,029,326 -1,756 -0.2% 0.00% $4.5M β€”
2024 Q4 ADDED 1,031,082 +3,428 +0.3% 0.00% $4.8M β€”
2024 Q3 ADDED 1,027,654 +18,195 +1.8% 0.00% $7.2M β€”
2024 Q2 ADDED 1,009,459 +102,308 +11.3% 0.00% $6.9M β€”
2024 Q1 REDUCED 907,151 -3,281,883 -78.3% 0.00% $12.8M β€”
2023 Q4 UNCHANGED 4,189,034 β€” 0% 0.00% $3.2M β€”
2023 Q3 ADDED 4,189,034 +127,000 +3.1% 0.00% $6.3M β€”
2023 Q2 REDUCED 4,062,034 -81,097 -2.0% 0.00% $6.5M β€”
28 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding ADVM

As of 2025 Q3 β€” sorted by position size

BML Capital Management, LLC 3Y 12.68% Versant Venture Management, LLC 3Y 7Y 1.08% 5AM Venture Management, LLC 3Y 0.9% TCG Crossover Management, LLC 3Y 0.37% Frazier Life Sciences Management, L.P. 3Y 0.28% Pale Fire Capital SE 3Y 0.18% REGENERON PHARMACEUTICALS, INC. 0.12% Soleus Capital Management, L.P. 3Y 0.07% Quinn Opportunity Partners LLC 3Y 7Y 0.01% Waverly Advisors, LLC 3Y 7Y 0.01%
← Back to VANGUARD GROUP INC Holdings